[Use of dalargin in the treatment of acute cholecystopancreatitis complicated by obstructive jaundice].
Skomarovskiĭ
A Ts
ATs
Zemskov
V S
VS
Skomarovskiĭ
A A
AA
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D002764:Cholecystitis / Q000150:complications / Q000188:drug therapy*; D002779:Cholestasis / Q000209:etiology*; D016308:Enkephalin, Leucine-2-Alanine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000150:complications / Q000188:drug therapy*; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Primenenie dalargina v lechenii ostrogo kholetsistopankreatita, oslozhnennogo obturatsionnoĭ zheltukhoĭ.